In vitro activity of apalcillin compared with those of piperacillin and carbenicillin against 6,797 bacterial isolates from four separate medical centers
- 1 May 1984
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 25 (5) , 669-671
- https://doi.org/10.1128/aac.25.5.669
Abstract
Quantitative susceptibility tests were performed in four separate medical centers, in which apalcillin was compared with piperacillin and carbenicillin. Data from tests of 6,797 isolates confirmed that apalcillin and piperacillin had nearly identical spectra of activity but that apalcillin was significantly more active against Pseudomonas aeruginosa (MIC required to inhibit 90% of strains, 2.0 versus 64 micrograms/ml) and Acinetobacter calcoaceticus subsp. anitratus (MIC required to inhibit 90% of strains, 2.0 versus 16 micrograms/ml). Against 166 anaerobic bacterial isolates, apalcillin demonstrated in vitro activity.Keywords
This publication has 7 references indexed in Scilit:
- Comparative pharmacokinetics of apalcillin and piperacillinAntimicrobial Agents and Chemotherapy, 1984
- In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporinsAntimicrobial Agents and Chemotherapy, 1982
- beta-Lactam resistance in Serratia marcescens: comparison of action of benzylpenicillin, Apalcillin, Cefazolin, and ceftizoximeAntimicrobial Agents and Chemotherapy, 1981
- New Antipseudomonal Penicillin, PC-904: Affinity to Penicillin-Binding Proteins and Inhibition of the Enzyme Cross-Linking PeptidoglycanAntimicrobial Agents and Chemotherapy, 1978
- Antibacterial Activity of Apalcillin (PC-904) Against Gram-Negative Bacilli, Especially Ampicillin-, Carbenicillin-, and Gentamicin-Resistant Clinical IsolatesAntimicrobial Agents and Chemotherapy, 1978
- PC-904, a New Semisynthetic PenicillinAntimicrobial Agents and Chemotherapy, 1978
- PC-904, a Novel Broad-Spectrum Semisynthetic Penicillin with Marked Antipseudomonal Activity: Microbiological EvaluationAntimicrobial Agents and Chemotherapy, 1976